Cactus Life Sciences Announces the Acquisition of Nspm and EluSCIdate
Cactus Life Sciences Announces the Acquisition of Nspm and EluSCIdate
nspm's rare disease expertise and global event proficiency expand Cactus Life Sciences' services amidst exciting buy-and-build strategy
nspm 的罕見病專業知識和全球活動熟練程度在激動人心的 “買進建造” 戰略中擴展了 Cactus Life Sciences 的服務
PRINCETON, NJ / ACCESSWIRE / April 24, 2024 / Cactus Life Sciences, a leading global scientific communications agency that works with blue chip pharma and biotechnology companies, announced today that they have acquired nspm and eluSCIdate, two dynamic medical communications and publications companies headquartered in Meggen, Switzerland with an office in the UK.
新澤西州普林斯頓/ACCESSWIRE/2024年4月24日/與藍籌製藥和生物技術公司合作的全球領先科學傳播機構Cactus Life Sciences今天宣佈，他們已經收購了總部位於瑞士梅根並在英國設有辦事處的兩家動態醫療傳播和出版公司nspm和eLuscidate。
logo lock up of nspm and eluSCIdate
nspm 和 eLusciDate 的徽標鎖定
Cactus Life Sciences, headquartered in Princeton, New Jersey, was formed in 2010 and is best known for its transformational global operating models that provide best in class science, innovation, and efficiency. Founded 27 years ago, nspm brings extensive expertise in medical communications, publications, and event management, with a focus on rare diseases. Its sister company eluSCIdate was founded in 2020 and focuses on medical and scientific publications, combining extensive experience in medical writing with creative flair to deliver high-quality publications.
Cactus Life Sciences總部位於新澤西州普林斯頓，成立於2010年，以其提供一流科學、創新和效率的變革性全球運營模式而聞名。nspm 成立於 27 年前，在醫學傳播、出版物和活動管理方面擁有豐富的專業知識，專注於罕見疾病。其姊妹公司eLusciDate成立於2020年，專注於醫學和科學出版物，將豐富的醫學寫作經驗與創造性天賦相結合，提供高質量的出版物。
This collaboration signifies a major step forward in enhancing services for our biopharma clients, ensuring a comprehensive and fully integrated global approach to medical communications. And provides a significant employee footprint in US, UK, Switzerland, and Japan.
此次合作標誌着在加強爲我們的生物製藥客戶提供的服務，確保採用全面和完全整合的全球醫療通信方法方面向前邁出了重要一步。並在美國、英國、瑞士和日本提供大量員工。
"As Cactus Life Sciences embarks on its forthcoming buy-and-build strategy, we're excited to unveil our first acquisition that shares so many of the same values as CACTUS, stated Oliver Dennis, the new Chairman of Cactus Life Sciences. "As we move forward, we seek partnerships that prioritize our people and clients alongside our strategic growth."
仙人掌生命科學新任董事長奧利弗·丹尼斯表示：“在Cactus Life Sciences開始其即將推出的收購和建造戰略之際，我們很高興宣佈我們的第一筆收購，該收購與CACTUS有許多相同的價值。”“在我們向前邁進的過程中，我們尋求合作伙伴關係，在戰略增長的同時優先考慮我們的員工和客戶。”
Rare diseases individually affect a small number of people, but collectively affect over 300 million worldwide, presenting significant challenges for patients and medical professionals. nspm's rare disease expertise addresses unmet needs for patients and society. Sabine Stotz, PhD, Managing Director, nspm, noted "This strategic alliance is a testament to the shared vision of excellence between Cactus Life Sciences, nspm and eluSCIdate. Together, our goal is to enrich the global landscape of scientific communications creating an even greater impact on healthcare professionals and the patients they treat."
罕見疾病單獨影響少數人，但共同影響全球超過3億人，這給患者和醫療專業人員帶來了重大挑戰。nspm的罕見病專業知識可以解決患者和社會未得到滿足的需求。nspm董事總經理薩賓·斯托茲博士指出：“這種戰略聯盟證明了Cactus Life Sciences、nspm和eLusciDate之間共同的卓越願景。我們的共同目標是豐富全球科學傳播格局，對醫療保健專業人員及其治療的患者產生更大的影響。”
Elvira Dsouza, President, Cactus Life Sciences remarked, "Cactus Life Sciences stands out for its unwavering commitment to excellence, innovation, and future readiness. With a focus on integrating cutting-edge technology, notably AI, we aim to elevate scientific content creation to contribute to a more accessible, informed, and transformative healthcare landscape."
仙人掌生命科學總裁埃爾維拉·德索扎表示：“仙人掌生命科學因其對卓越、創新和爲未來做好準備的堅定承諾而脫穎而出。我們專注於整合尖端技術，尤其是人工智能，旨在提升科學內容創作，爲更容易獲得、更知情和更具變革性的醫療保健格局做出貢獻。”
About Cactus Life Sciences (cactuslifesciences.com): Cactus Life Sciences is a medical communication company that provides scientific strategy and content across the healthcare continuum, anywhere in the world - with a focus on science, innovation, and efficiency. We work alongside leading healthcare companies to establish the optimal role of medicines and encourage positive behaviors (physician and patient) that improve patient outcomes.
關於仙人掌生命科學（cactuslifesciences.com）：Cactus Lifesciences是一家醫療傳播公司，在世界任何地方提供醫療保健領域的科學戰略和內容，重點是科學、創新和效率。我們與領先的醫療保健公司合作，確定藥物的最佳作用，鼓勵積極的行爲（醫生和患者）以改善患者預後。
About nspm (): nspm is a successful and dynamic medical communications company founded in 1997 with offices in Switzerland and the UK. nspm provides a complete range of medical writing, project management, and strategic medical communications solutions for the pharmaceutical and biotech industry across a range of therapeutic areas, with a focus on rare diseases. Our employees are committed to crafting high-quality, cost-effective solutions that exceed clients' expectations through scientific excellence, professionalism, and creativity.
關於 nspm ()：nspm 是一家成功且充滿活力的醫療傳播公司，成立於 1997 年，在瑞士和英國設有辦事處。nspm 爲製藥和生物技術行業提供涵蓋一系列治療領域的全方位醫學寫作、項目管理和戰略醫學傳播解決方案，重點關注罕見疾病。我們的員工緻力於通過卓越的科學、專業精神和創造力打造高質量、具有成本效益的解決方案，這些解決方案超出了客戶的期望。
About eluSCIdate (): eluSCIdate is a medical writing agency founded in 2020 that specializes in scientific publications, providing support for the entire publication process. We use a wealth of experience in medical writing to deliver high-quality manuscripts, posters, and slides to our clients. At eluSCIdate, we are passionate about science and committed to providing clarity in scientific messaging. Through effective communication, we work with our clients to ensure their science stands out from the crowd.
關於eLusciDate ()：eLusciDate是一家醫學寫作機構，成立於2020年，專門出版科學出版物，爲整個出版過程提供支持。我們利用豐富的醫學寫作經驗爲客戶提供高質量的手稿、海報和幻燈片。在 eLusciDate，我們對科學充滿熱情，並致力於提供清晰的科學信息。通過有效的溝通，我們與客戶合作，確保他們的科學在人群中脫穎而出。
Contact Information
聯繫信息
Laura Perry
VP of Strategy and Marketing
inquiries@cactuslifesciences.com
7327121005
勞拉·佩裏
戰略與營銷副總裁
inquiries@cactuslifesciences.com
7327121005
SOURCE: Cactus Life Sciences
來源：仙人掌生命科學